Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 120-66-1 | MDL No. : | MFCD00014961 |
Formula : | C9H11NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 149.19 | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.72 |
TPSA : | 29.1 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.61 cm/s |
Log Po/w (iLOGP) : | 1.87 |
Log Po/w (XLOGP3) : | 0.85 |
Log Po/w (WLOGP) : | 1.76 |
Log Po/w (MLOGP) : | 1.84 |
Log Po/w (SILICOS-IT) : | 1.84 |
Consensus Log Po/w : | 1.63 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.57 |
Solubility : | 4.0 mg/ml ; 0.0268 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.04 |
Solubility : | 13.5 mg/ml ; 0.0903 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.15 |
Solubility : | 0.105 mg/ml ; 0.000705 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P264-P270-P280-P301+P312+P330-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P501 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.78 g | Stage #1: With nitric acid In acetic anhydride at 10 - 12℃; for 2.5 h; Stage #2: With sulfuric acid In water for 3 h; Reflux |
A slightly modified procedure of Howard was applied [27]. Toluidine (1a or 1b; 53.5mL, 0.5mol) was introduced, in small portions and under constant stirring, to Ac2O (325mL). The obtained solution was cooled to 12–13°C in an ice-salt bath. After that, under stirring and at a rate which maintained the temperature within the limits of 10–12°C, 70percent HNO3 (63mL) was added dropwise to the reaction mixture. The addition was completed in 2.5h and the solution was poured, with stirring, into 1.5L of ice-water. The precipitate (cream-colored solid) of acetamide (3a, or mixture of 3b and 3c) was collected on a Büchner funnel, washed with four 250-mL portions of ice-water and partially dried by suction. The moist acetamide (3a, or mixture of 3b and 3c) was mixed with 70percent H2SO4 (100mL) and stirred at reflux for 3h. The hydrolysis product of acetamide 3b, 2-methyl-6-nitroaniline (4b), was isolated from the reaction mixture by steam distillation. The bright orange needles of 4b, which separated when the distillate was cooled, were collected on a Büchner funnel and dried in a vacuum desiccator. In the case of the hydrolysis of acetamide 3a, the warm reaction mixture was diluted with 350mL of water and made alkaline with 10percent aq. NaOH. After cooling to room temperature 4-methyl-2-nitroaniline (4a) precipitated as a brown powder that was separated by vacuum filtration, washed with three 200-mL portions of water, and dried in a vacuum desiccator. The yield was 53.6percent (40.73g) and 52.3percent (39.78g) for compounds 4a and 4b, respectively. |
[ 56891-59-9 ]
N-(4-Amino-2-methylphenyl)acetamide
Similarity: 0.97
[ 2050-44-4 ]
N-(2,5-Dimethylphenyl)acetamide
Similarity: 0.97
[ 53997-74-3 ]
N-(3-Amino-2,4,6-trimethylphenyl)acetamide
Similarity: 0.97
[ 65999-76-0 ]
N-(3-Amino-2-methylphenyl)acetamide
Similarity: 0.97
[ 56891-59-9 ]
N-(4-Amino-2-methylphenyl)acetamide
Similarity: 0.97
[ 2050-44-4 ]
N-(2,5-Dimethylphenyl)acetamide
Similarity: 0.97
[ 53997-74-3 ]
N-(3-Amino-2,4,6-trimethylphenyl)acetamide
Similarity: 0.97
[ 65999-76-0 ]
N-(3-Amino-2-methylphenyl)acetamide
Similarity: 0.97
[ 56891-59-9 ]
N-(4-Amino-2-methylphenyl)acetamide
Similarity: 0.97
[ 2050-44-4 ]
N-(2,5-Dimethylphenyl)acetamide
Similarity: 0.97
[ 53997-74-3 ]
N-(3-Amino-2,4,6-trimethylphenyl)acetamide
Similarity: 0.97
[ 65999-76-0 ]
N-(3-Amino-2-methylphenyl)acetamide
Similarity: 0.97